RecruitingNot ApplicableNCT07579117

Endoscopic Video-Assisted Nipple-Sparing Mastectomy

EVA - Endoscopic Video-Assisted Nipple-Sparing Mastectomy (E-NSM): A Pilot Study


Sponsor

European Institute of Oncology

Enrollment

10 participants

Start Date

May 23, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Endoscopic video-assisted nipple-sparing mastectomy (E-NSM) is an advancement in minimally invasive breast surgery designed to reduce surgical trauma and improve cosmetic outcomes while maintaining strict oncologic safety. The procedure will be carried out by a dedicated surgical team in which at least one operator holds certified laparoscopic surgical training issued by a recognized scientific society, ensuring appropriate technical expertise and adherence to surgical safety standards.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria5

  • Female patients aged ≥18 years
  • Candidates for nipple-sparing mastectomy (NSM) with immediate reconstruction
  • Histologically confirmed invasive carcinoma cT1N0, or carriers of pathogenic germline mutations undergoing prophylactic mastectomy
  • Breast size I-III and absence of significant glandular ptosis
  • Signed informed consent

Exclusion Criteria10

  • Inflammatory breast cancer
  • Locally advanced clinical stage (cT2-T4 or N+)
  • Ductal carcinoma in situ (DCIS) without invasive component
  • Previous radiotherapy to the affected breast
  • Locoregional recurrence
  • Clinical conditions contraindicating prosthetic reconstruction
  • Indication for skin-sparing (SSM) or skin-reducing mastectomy (SRM)
  • Ongoing or completed neoadjuvant chemotherapy before surgery
  • Refusal or inability to sign informed consent
  • Inability to complete scheduled follow-up

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREEndoscopic video-assisted nipple-sparing mastectomy (E-NSM)

Endoscopic video-assisted nipple-sparing mastectomy (E-NSM) is an advancement in minimally invasive breast surgery designed to reduce surgical trauma and improve cosmetic outcomes while maintaining strict oncologic safety. Recent prospective studies and meta-analyses have shown encouraging results in terms of technical feasibility, reduced flap-related complications, and higher patient satisfaction compared with the conventional open approach.


Locations(1)

Istituto Europeo di Oncologia

Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07579117


Related Trials